Related references
Note: Only part of the references are listed.Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Breast cancer quantitative proteome and proteogenomic landscape
Henrik J. Johansson et al.
NATURE COMMUNICATIONS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Emerging functional roles of nuclear receptors in breast cancer
Tram B. Doan et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Kuan-lin Huang et al.
NATURE COMMUNICATIONS (2017)
Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer
Angie M. Torres-Adorno et al.
CLINICAL CANCER RESEARCH (2017)
Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
Michelle A. Hughes et al.
MOLECULAR CELL (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Proteomic maps of breast cancer subtypes
Stefka Tyanova et al.
NATURE COMMUNICATIONS (2016)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2014)
Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
Ning Qing Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Rehan Akbani et al.
NATURE COMMUNICATIONS (2014)
Challenges translating breast cancer gene signatures into the clinic
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
PPARs at the crossroads of lipid signaling and inflammation
Walter Wahli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Programmed Cell Death in Animal Development and Disease
Yaron Fuchs et al.
CELL (2011)
Management of breast cancer with targeted agents: importance of heterogenicity
Serena Di Cosimo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High Precision Quantitative Proteomics Using iTRAQ on an LTQ Orbitrap: A New Mass Spectrometric Method Combining the Benefits of All
Thomas Koecher et al.
JOURNAL OF PROTEOME RESEARCH (2009)
PPARs Mediate Lipid Signaling in Inflammation and Cancer
Liliane Michalik et al.
PPAR RESEARCH (2008)
Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research
Sebastian Wiese et al.
PROTEOMICS (2007)
The CD95(APO-1/Fas) DISC and beyond
ME Peter et al.
CELL DEATH AND DIFFERENTIATION (2003)
Share Paper
